Atrial Flutter Typical Clinical Trial
Official title:
Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter
The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT06056557 -
Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy
|
N/A | |
Recruiting |
NCT04678258 -
Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation
|
N/A | |
Not yet recruiting |
NCT06406686 -
Ablation Index in Standard vs. High Power Radiofrequency Ablation for Typical Atrial Flutter: A Randomized Study (AITAF)
|
N/A | |
Recruiting |
NCT04900831 -
Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping
|
||
Completed |
NCT03401099 -
Cryoballoon Ablation as First Line Treatment of Atrial Flutter
|
N/A |